Cortica Closes $40 Million Series D Extension Led by CVS Health Ventures, LRVHealth, and Other Strategic Investors, Bringing Round Total to $115 Million

Funding to Support Expanded Access to Whole-Child, Value-Based, Outcomes-Driven Autism Care Cortica, the United States’ leading physician-led, whole-child, value-based autism services company, has raised $40 million in a Series D extension, bringing the total Series D round to $115 million. The extension was entirely strategic, led by CVS Health Ventures, in conjunction with LRVHealth, Ascension Investment Management (a subsidiary of Ascension), and the University of Wisconsin Foundation. “There is an increasing need for access to evidence-based care for children with neurodivergent conditions and autism, and we believe that Cortica is well positioned to help support our members and their dependents by deploying an integrated, medical and behavioral care model,” said Justin Brock, Partner at CVS Health Ventures. “Through our investment and collaboration with Cortica, we believe that we can help improve the overall quality of care for individuals with autism, as well as provide support to their caregivers.” Founded to fix the fragmented care journey families typically experience when seeking diagnoses and treatments, Cortica’s whole-child, whole-family, value-based care model for autism spans medical treatment, neurodiversity-affirming behavioral therapy, developmental therapy (encompassing speech, occupational, physical, and music therapies), and family support and counseling. Cortica’s care model has shown improved outcomes a...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT AIM Ascension Ascension Investment Management Cortica CVS Health Ventures Ellen Herlacher Health IT Funding Health IT Fundings Health IT Investment Justin Brock LRVHealth Neil Hattangadi MD Unive Source Type: blogs